Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Telesis Bio, Inc. - Common Stock
(NQ:
TBIO
)
1.400
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EDT, Sep 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Telesis Bio, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
March 31, 2023
New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Synthetic Biology Workstation
From
Telesis Bio
Via
GlobeNewswire
Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 22, 2023
Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday.
Via
Benzinga
Telesis Bio Earnings Perspective: Return On Capital Employed
March 22, 2023
Via
Benzinga
A Preview Of Telesis Bio's Earnings
March 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 22, 2023
Via
Benzinga
Why GameStop Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
March 22, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 22, 2023
The biggest pre-market stock movers are making waves on Wednesday with huge gainers and losers worth watching this morning!
Via
InvestorPlace
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
March 21, 2023
From
Telesis Bio
Via
GlobeNewswire
Earnings Scheduled For March 21, 2023
March 21, 2023
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million.
Via
Benzinga
Telesis Bio to Present at Festival of Biologics Conference
March 16, 2023
Daniel Gibson, Ph.D., CTO and Co-founder to Present “Building Biology Overnight: Eliminating Synthesis Bottlenecks with Hands-free Automated Synthetic Biology Solutions”
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023
March 09, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio to Present at the Cowen 43rd Annual Healthcare Conference
February 27, 2023
From
Telesis Bio
Via
GlobeNewswire
Telesis Bio Releases BioXp® Select mRNA Synthesis Kit to Expand the Utility, Speed, and Impact of Its Automated Synthetic Biology Workstation
February 16, 2023
Scientists Can Now Begin the mRNA Synthesis Process from Their Own Sequence or Plasmid DNA
From
Telesis Bio
Via
GlobeNewswire
Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 11, 2023
Gainers Broadwind Inc (NASDAQ: BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.